DATA GRAPHICS | Product Development
Data Bytes: COVID-19 mAbs in clinical testing
A roundup of the clinical status, target populations and manufacturing capacity of COVID-19 mAbs
October 8, 2020 1:26 AM UTC
At least 10 neutralizing mAbs against SARS-CoV-2 have started clinical trials, four of which have advanced to late-stage testing.
Several developers are evaluating the approach across a range of disease settings, from prophylactic use in high-risk individuals to treatment for hospitalized patients...